The Column Group Overview

  • Investor Type
  • Venture Capital

  • Status
  • Active

  • Professionals
  • 19

Professionals
  • Investments
  • 103

  • Portfolio
  • 26

  • Exits
  • 25

Exits

The Column Group General Information

Description

Founded in 2007, The Column Group is a venture capital investment firm based in San Francisco, California. The firm prefers to invest in early-stage drug discovery companies based on their unique scientific platforms and the potential to deliver multiple breakthrough therapeutics.

Contact Information

Year Founded
2007
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Primary Office
  • 1 Letterman Drive Building D
  • Suite DM-900
  • San Francisco, CA 94129
  • United States
+1 (415) 000-0000

The Column Group Investments (103)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Neurona Therapeutics 22-Dec-2022 Later Stage VC 0000 Drug Discovery Clinical Trials - Phase 1 000000 00000 00.0
0000000000 06-Dec-2022 00000 00000 00000 Drug Discovery Generating Revenue 0000000 0000000 00.0
00000 000000000000 29-Nov-2022 00000 00000 000.00 Drug Discovery Generating Revenue
0000000 0000000000 28-Nov-2022 00000 00000 00000 Drug Discovery Clinical Trials - Phase 2 000000 00000 00.0
0000000 000 30-Sep-2022 00000 00000 000.00 Drug Discovery Generating Revenue 0000000 000 00.0
000000 00000000000 25-Jul-2022 00000 00000 00000 Drug Discovery Generating Revenue 00000 0000000000
00000 000000000000 24-Mar-2022 00000 00000 0000 Drug Discovery Generating Revenue 0000 0000 00.0
000000 000000 22-Mar-2022 00000 00000 000.00 Drug Discovery Generating Revenue 00000 0000000000
Plexium 28-Feb-2022 Later Stage VC 00000 Drug Discovery Startup 0000000 0000000 00.0
InduPro (Biotechnology) 18-Feb-2022 Early Stage VC 0000 Biotechnology Startup 0000000 0000000 00.0
You’re viewing 10 of 103 investments. Get the full list »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

The Column Group Exits (25)

Company Name Exit Date Exit Type Exit Size
eFFECTOR Therapeutics 26-Aug-2021 Reverse Merger 00000
000000 00000000000 30-Jul-2021 000 00000
0000000000000 0000 15-Jul-2021 000000000000000000 00.000
00000 05-Mar-2021 000000 0000000000 00000
0000 0000000000000 13-Nov-2020 000000 0000000000 00000
00000 24-Jul-2020 000 00000
0000000000000 0000 17-Jun-2020 000000 0000000000 00000
0000 0000000000000 24-Apr-2020 000 00000
Revolution Medicines 13-Feb-2020 IPO 00000
RAPT Therapeutics 07-Feb-2020 Public Investment 2nd Offering 0000
You’re viewing 10 of 25 exits. Get the full list »

The Column Group Fund Performance

Fund Name Vintage Size Dry Powder DPI RVPI TVPI IRR

This information is available in the PitchBook Platform. To explore The Column Group‘s full profile, request access.

Request a free trial

The Column Group Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

The Column Group Team (34)

Name Title Deals Funds Boards Office
James Evangelista Chief Financial Officer 0 San Francisco, CA
Peter Svennilson Co-Founder & Managing Partner 00 0 0 San Francisco, CA
Peter Svennilson Founder & Managing Partner 0 San Francisco, CA
David Goeddel Ph.D Managing Partner 00 0 0 San Francisco, CA
Jeffrey Goater Venture Partner 0 San Francisco, CA
You’re viewing 5 of 34 team members. Get the full list »

The Column Group Co-Investors (151)

Name With Exits Lead Partner Series Industry
Casdin Capital 8 0 0 Series chart Industry bar
Euclidean Capital 0 0 Series chart Industry bar
Foresite Capital Management 0 0 0 Series chart Industry bar
Nextech Invest 0 0 0 Series chart Industry bar
Lux Capital 0 0 Series chart Industry bar
You’re viewing 5 of 151 co-investors. Get the full list »